TG Therapeutics (TGTX) Operating Margin (2013 - 2026)
TG Therapeutics (TGTX) operating margin from Sep 30, 2013 to Mar 31, 2026. The current TG Therapeutics (TGTX) operating margin is 16.98%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of TG Therapeutics (TGTX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 20.01% | +57.01% |
| 2024 | 12.74% | +44.35% |
| 2023 | 8.83% | -100.11% |
| 2022 | -7825.09% | +51.84% |
| 2021 | -5153.51% | -97.17% |
| 2020 | -182393.33% | +61.84% |
| 2019 | -112700.00% | -3.07% |
| 2018 | -116266.67% | +46.91% |
| 2017 | -79140.00% | +50.32% |
| 2016 | -52646.67% | -31.24% |
| 2013 | -76566.67% | -43.07% |
| 2012 | -134500.00% | N/A |
Comparison TG Therapeutics (TGTX) operating margin with competitors
TG Therapeutics (TGTX) operating margin is 16.98%.